Degarelix acetate

Overview

Degarelix is a synthetic gonadotropin-releasing hormone receptor (GNRHR) antagonist. It decreases tumor volume of Dunning R3327H prostate tumor flank implants in rats when administered at a dose of 1 mg/kg per month. Formulations containing degarelix have been used in the treatment of advanced prostate cancer. Sequence: Ac-D-2Nal-D-Phe(4-Cl)-D-3Pal-Ser-Phe(4-S-dihydroorotamido)-D-Phe(4-ureido)-Leu-Lys(iPr)-Pro-D-Ala-NH2.CH3CO2H Source summary: Degarelix acetate is a potent GnRH receptor antagonist used in advanced hormone regulation and reproductive research studies. Request a quotation today!

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | GNRH Receptor

Product Information

• Catalog No.: B2693-008802
• CAS No.: 934016-19-0
• Molecular Formula: C82H103ClN18O16.C2H4O2
• Molecular Weight: 1692.31
• Purity: ≥98%
• Storage: Store at -20°C
• Solubility: Soluble in DMSO

Source

Original product source